Cite
Nalkurthi C, Schroder WA, Melino M, et al. ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis. JHEP Rep. 2021;4(1):100386doi: 10.1016/j.jhepr.2021.100386.
Nalkurthi, C., Schroder, W. A., Melino, M., Irvine, K. M., Nyuydzefe, M., Chen, W., Liu, J., Teng, M. W. L., Hill, G. R., Bertolino, P., Blazar, B. R., Miller, G. C., Clouston, A. D., Zanin-Zhorov, A., & MacDonald, K. P. A. (2022). ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis. JHEP reports : innovation in hepatology, 4(1), 100386. https://doi.org/10.1016/j.jhepr.2021.100386
Nalkurthi, Christina, et al. "ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis." JHEP reports : innovation in hepatology vol. 4,1 (2022): 100386. doi: https://doi.org/10.1016/j.jhepr.2021.100386
Nalkurthi C, Schroder WA, Melino M, Irvine KM, Nyuydzefe M, Chen W, Liu J, Teng MWL, Hill GR, Bertolino P, Blazar BR, Miller GC, Clouston AD, Zanin-Zhorov A, MacDonald KPA. ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis. JHEP Rep. 2021 Oct 06;4(1):100386. doi: 10.1016/j.jhepr.2021.100386. eCollection 2022 Jan. PMID: 34917911; PMCID: PMC8645924.
Copy
Download .nbib